Quick Answer
Profound Medical Corp. reported Operating Income of -$41.25 million for fiscal year 2025.
Profound Medical Corp. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$41.25M | -24.8% |
| 2024 | -$33.06M | -15.4% |
| 2023 | -$28.65M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$8.91M | +0.9% | +35.4% |
| June 30, 2025 | -$13.81M | -76.1% | -23.6% |
| March 31, 2025 | -$11.17M | -41.8% | -24.1% |
| September 30, 2024 | -$9.00M | — | -14.7% |
| June 30, 2024 | -$7.84M | — | +0.4% |
| March 31, 2024 | -$7.88M | — | — |
- Profound Medical Corp. showed a decrease of -24.8% in Operating Income compared to the prior fiscal year.
- Over the 2023–2025 period, Profound Medical Corp.’s operating income has declined by 44.0% (from -$28.65 million to -$41.25 million).
- The most recent figure is from Profound Medical Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: